[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100618824":3},{"organization":4,"armGroups":7,"interventions":31,"overallOfficials":10,"centralContacts":41,"locations":50,"responsibleParty":67,"collaborators":10,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":71,"sex":77,"minAge":78,"maxAge":10,"enrollmentInfo":79,"targetDuration":10,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":90,"overallStatus":95,"whyStopped":10,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"Fondazione ISIDE","OTHER",[8,15,19,23,27],{"label":9,"type":10,"description":11,"interventionNames":12},"Psoriasis Cohort",null,"Adult patients (≥18 years) diagnosed with moderate-to-severe psoriasis according to clinical criteria, treated with systemic conventional and\u002For biologic therapies at participating Italian dermatology centers. No intervention is administered; data are collected retrospectively from medical records.",[13,14],"Drug: Conventional Systemic Therapies","Drug: Biologic Therapies",{"label":16,"type":10,"description":17,"interventionNames":18},"Atopic Dermatitis Cohort","Adult patients (≥18 years) diagnosed with moderate-to-severe atopic dermatitis, treated with systemic conventional and\u002For biologic therapies at participating Italian dermatology centers. No intervention is administered; data are collected retrospectively from medical records.",[13,14],{"label":20,"type":10,"description":21,"interventionNames":22},"Alopecia Areata Cohort","Adult patients (≥18 years) diagnosed with alopecia areata, treated with systemic therapies at participating Italian dermatology centers. No intervention is administered; data are collected retrospectively from medical records.",[13,14],{"label":24,"type":10,"description":25,"interventionNames":26},"Vitiligo Cohort","Adult patients (≥18 years) diagnosed with vitiligo, treated at participating Italian dermatology centers. No intervention is administered; data are collected retrospectively from medical records.",[13,14],{"label":28,"type":10,"description":29,"interventionNames":30},"Hidradenitis Suppurativa Cohort","Adult patients (≥18 years) diagnosed with hidradenitis suppurativa, treated with systemic conventional and\u002For biologic therapies at participating Italian dermatology centers. No intervention is administered; data are collected retrospectively from medical records",[13,14],[32,37],{"type":33,"name":34,"description":35,"armGroupLabels":36,"otherNames":10},"DRUG","Conventional Systemic Therapies","Retrospective observation of conventional systemic treatments prescribed in routine clinical practice, including but not limited to methotrexate, cyclosporine, acitretin, and other conventional agents. No drugs are administered as part of this study; treatment data are collected from existing medical records.",[20,16,28,9,24],{"type":33,"name":38,"description":39,"armGroupLabels":40,"otherNames":10},"Biologic Therapies","Retrospective observation of biologic treatments prescribed in routine clinical practice, including but not limited to TNF-α inhibitors, IL-17 inhibitors, IL-23 inhibitors, IL-4\u002FIL-13 inhibitors, and JAK inhibitors. No drugs are administered as part of this study; treatment data are collected from existing medical records.",[20,16,28,9,24],[42,47],{"name":43,"role":44,"phone":45,"phoneExt":10,"email":46},"Dario Gattuso","CONTACT","3792225577","ricerca@fondazioneiside.org",{"name":48,"role":44,"phone":10,"phoneExt":10,"email":49},"Alessandra Narcisi","info@fondazioneiside.org",[51],{"facility":52,"status":10,"city":53,"state":54,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":64},"IRCCS Istituto Clinico Humanitas - Dermatology Unit","Rozzano","Lombardy","20089","Italy","IT",{"type":59,"coordinates":60},"Point",[61,62],9.1559,45.38193,{"lat":62,"lon":61},[65],{"name":66,"role":44,"phone":10,"phoneExt":10,"email":10},"Antonio Costanzo, MD",{"type":68,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100618824","landscape-demographics-and-treatment-patterns-of-patients-with-immune-mediated-inflammatory-skin-diseases-in-italian-clinical-practice-100618824",false,"NCT07336641","LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice","LANDSCAPE - Demographic Characteristics and Treatment Profiles of Patients Affected by Inflammatory Skin Diseases (Psoriasis, Atopic Dermatitis, Alopecia Areata, Vitiligo, Hidradenitis Suppurativa) in Italian Clinical Practice","LANDSCAPE","Inclusion Criteria:\n\n1. Documented diagnosis of psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.\n2. Age 12 years or older at the first recorded visit.\n3. Eligible for or treated with systemic therapies.\n4. At least one documented visit during January 2016 to December 2025.\n5. No opt-out exercised.\n\nExclusion Criteria:\n\n1. Opt-out exercised.\n2. Medical records with insufficient data.","ALL","12 Years",{"count":80,"type":81},20000,"ESTIMATED","OBSERVATIONAL","This multicenter retrospective observational registry study will collect existing clinical data from Italian centers to describe epidemiology, treatment patterns, clinical evolution, safety, and comorbidities in patients aged 12 years and older with psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.",[85,86,87,88,89],"Psoriasis","Atopic Dermatitis","Vitiligo","Alopecia Areata","Hidradenitis Suppurativa",[91,92,93,94,56],"Registry","Real-World Evidence","Treatment Patterns","Dermatology","NOT_YET_RECRUITING","2026-01-13",{"date":98,"type":99},"2026-01-15","ACTUAL",{"date":101,"type":81},"2026-01",{"date":103,"type":81},"2028-01",{"name":5,"class":6},1]